Crossref
Assessment of structure-modifying drugs in osteoarthritis: surrogate or hard clinical end points?
Future Rheumatology · 2006
DOI: 10.2217/17460816.1.2.199 ↗Kurz gefasst
Fachartikel in der Zeitschrift Future Rheumatology, 2006. Verfasst von Olivier Bruyere und 1 weiteren Autor:innen. Die Arbeit nennt 60 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bruyere, O., & Reginster, J. (2006). Assessment of structure-modifying drugs in osteoarthritis: surrogate or hard clinical end points?. Future Rheumatology. https://doi.org/10.2217/17460816.1.2.199
Vancouver
Bruyere O, Reginster J. Assessment of structure-modifying drugs in osteoarthritis: surrogate or hard clinical end points?. Future Rheumatology. 2006. doi:10.2217/17460816.1.2.199
BibTeX
@article{Bruyere2006,
author = {Bruyere, Olivier and Reginster, Jean-Yves},
title = {Assessment of structure-modifying drugs in osteoarthritis: surrogate or hard clinical end points?},
journal = {Future Rheumatology},
year = {2006},
doi = {10.2217/17460816.1.2.199}
}
EUVIMED